Prediction and prevention of pregnancy (gestation) complications. Is it possible?

• Alina V. Solovieva
• Dianna A. Gevorgyan

Abstract

Background. The results of reported data of Russian Federal State Statistics Service (FSSS) on the course of pregnancy, childbirth and perinatal outcomes over the past 10 years are hardly comforting. About 40% of women carry a pregnancy and give birth physiologically. Extragenital and genital diseases occur among 58.7-75.3% of pregnant women, which undoubtedly affects the course of gestation and causes numerous complications. Approximately 0.5% of newborns are born with congenital disorder and often it leads to disability of the child. Of particular importance is the lack of basic micronutrients (folic acid, iron, etc.) due to a lack of diet or chronic diseases to women.

Aim - to analyze modern scientific publications on the prediction and prevention of major pregnancy complications.

Material and methods. International reviews over the past 15 years from PubMed, Embase, MEDLINE, Cochrane databases, which included a series of cases and registers on various aspects of predicting and preventing major pregnancy complications.

Conclusion. Prediction and prevention of pregnancy complications and adverse perinatal outcomes are the basis of pregravid preparation. Nutritional support is an important step in the periconceptional period. The use of vitamin-mineral complexes (folic acid, iron, etc.) improves the health of women, which contributes to the normal course of pregnancy and the birth of healthy children.

Keywords:pregnancy, pre-conception care, folic acid, iron, Elevit

References

1. Gromova O.A. Evidence-based medicine and vitamin therapy during pregnancy: replicas of the pros and cons. StatusPraesens. Ginekologiya, akusherstvo, besplodnyy brak [StatusPraesens. Gynecology, Obstetrics, Barren Marriage]. 2011; 3 (6): 38-44. (in Russian)

2. World Health Organization. Congenital Anomalies [Electronic Resource]. URL: http://www.who.int/mediacentre/factsheets/fs370/en/ (date of access August 15, 2014)

3. Agopian A.J., Tinker S.C., Lupo P.J., et al. National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol. 2013; 97: 42-6.

4. Flores A.L., Vellozzi C., Valencia D., Sniezek J. Global burden of neural tube defects, risk factors, and prevention. Indian J Commun Health. 2014; 26 (1): 3-5.

5. Cordero A.M., Crider K.S., Rogers L.M., Cannon M.J., et al. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep. 2015; 64 (15): 421-3.

6. McKeating A., Farren M., Cawley S., et al. Maternal folic acid supplementation trends 2009-2013. Acta Obstet Gynecol Scand. 2015; 94 (7): 727-33.

7. Fekete K., Berti C., Trovato M., et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr J. 2012; 11: 75.

8. Hovdenak N., Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012; 164 (2): 127-32.

9. Stamm R.A., Houghton L.A. Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients. 2013; 5 (10): 3920-47.

10. Eskes TKAB. Clotting disorders and placental abruption: homocysteine - a new risk factor. Eur J Obstet Gynecol Reprod Biol. 2001; 95 (2): 206-12.

11. Singh M.D., Thomas P., Owens J., Hague W., et al. Potential role of folate in pre-eclampsia. Nutr Rev. 2015; 73 (10): 694-722.

12. Lu W.P., Lu M.S., Li Z.H., Zhang C.X. Effects of multimicronutrient supplementation during pregnancy on postnatal growth of children under 5 years of age: a meta-analysis of randomized controlled trials. PLoS One. 2014; 9 (2): e88496.

13. International Anemia Consultative Group. Report of the 2001 International Anemia Consultative Group Symposium. Why is iron important and what to do about it: a new perspective. Washington, DC: INACG Secretariat, 2002: 1-50.

14. Irwin R.E., Pentieva K., Cassidy T., Lees-Murdock D.J., et al. The interplay between DNA methylation, folate and neurocognitive development. Epigenomics. 2016; 8 (6): 863-79.

15. Rosenthal J., Casas J., Taren D., Alverson C.J., et al. Neural tube defects in Latin America and the impact of fortification: a literature review. Public Health Nutr. 2014; 17 (3): 537-50.

16. Pregravid training. Clinical Protocol. Moscow: StatusPraesens, 2016. (in Russian)

17. Keats E.C., Haider B.A., Tam E., Bhutta Z.A. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019; 3:004905.

18. Olukayode Akinlaja. Hematinics - still a neccessity in pregnancy. Gynaecol Perinatol. 2017; 1 (1): 98-9.

19. Iodine deficiency - a threat to the health and development of children in Russia: National report.Moscow, 2006. 124 р. (in Russian)

20. Czeizel A.E. Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy. Paediatr. Drugs. 2000; 2 (6): 43749.

21. Guideline: Daily Iron Supplementation in Adult Women and Adolescent Girls. Geneva: World Health Organization, 2016.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)